National Research ( (NRC) ) has released its Q4 earnings. Here is a breakdown of the information National Research presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
National Research Corporation, operating as NRC Health, is a leader in humanizing healthcare services by providing insightful market research and understanding consumer preferences in the healthcare sector. In the fourth quarter of 2024, NRC Health reported a slight decline in revenue to approximately $36.9 million from $38.0 million the previous year, alongside a decrease in earnings per diluted share from $0.36 to $0.28. The company maintained its strategic focus on shareholder returns, repurchasing 393,000 shares for around $7.3 million and distributing $2.8 million in dividends. Despite a decline in revenue and net income, NRC Health continues to show robust recurring contract value at $133.2 million, demonstrating its continued relevance and engagement in the healthcare market. The management remains focused on its strategic initiatives to drive growth and enhance shareholder value while navigating market challenges.
